Title : Purinergic-Glycinergic Interaction in Neurodegenerative and Neuroinflammatory Disorders of the Retina.

Pub. Date : 2021 Jun 8

PMID : 34201404






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The consequential changes in extracellular glycine concentration can lead to parallel changes in the activity of NR1/NR2B type NMDA receptors of which glycine is a mandatory agonist, and thereby may reduce neurodegenerative events in the retina. Glycine glutamate ionotropic receptor NMDA type subunit 1 Homo sapiens
2 The consequential changes in extracellular glycine concentration can lead to parallel changes in the activity of NR1/NR2B type NMDA receptors of which glycine is a mandatory agonist, and thereby may reduce neurodegenerative events in the retina. Glycine glutamate ionotropic receptor NMDA type subunit 1 Homo sapiens
3 We have hypothesized that glycine transporter 1 inhibitors and P2Y purinoceptor agonists may have therapeutic importance in neurodegenerative-neuroinflammatory disorders of the retina by decreasing NR1/NR2B NMDA receptor activity and production and release of a series of proinflammatory cytokines from microglial cells. Glycine glutamate ionotropic receptor NMDA type subunit 1 Homo sapiens